--- title: "European Union funds SK-IIDT-Vaxxas consortium for high-density microarray patch vaccines to enhance seasonal & pandemic flu protection." type: "News" locale: "en" url: "https://longbridge.com/en/news/277047763.md" description: "Consortium comprising SK, IDT, and Vaxxas introduced a high-density microarray patch (HD-MAP) for vaccines in Europe, aiming to enhance vaccine efficacy and availability. They are focused on developing HD-MAP vaccines with high immunogenicity for both seasonal and pandemic influenza. The initiative is set to address pressing immunization challenges by capitalizing on innovative technology." datetime: "2026-02-26T13:01:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277047763.md) - [en](https://longbridge.com/en/news/277047763.md) - [zh-HK](https://longbridge.com/zh-HK/news/277047763.md) --- # European Union funds SK-IIDT-Vaxxas consortium for high-density microarray patch vaccines to enhance seasonal & pandemic flu protection. Consortium comprising SK, IDT, and Vaxxas introduced a high-density microarray patch (HD-MAP) for vaccines in Europe, aiming to enhance vaccine efficacy and availability. They are focused on developing HD-MAP vaccines with high immunogenicity for both seasonal and pandemic influenza. The initiative is set to address pressing immunization challenges by capitalizing on innovative technology. ### Related Stocks - [ASMB.US](https://longbridge.com/en/quote/ASMB.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [GME.DE](https://longbridge.com/en/quote/GME.DE.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [VAXX.US](https://longbridge.com/en/quote/VAXX.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [VXRT.US](https://longbridge.com/en/quote/VXRT.US.md) ## Related News & Research - [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md) - [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md) - [BioNTech Reports Phase 1/2a Study Data For BNT323/DB-1303 In HER2-Expressing Endometrial Cancer](https://longbridge.com/en/news/282508084.md) - [FDA issues complete response letter to Replimune’s RP1 for melanoma](https://longbridge.com/en/news/282511585.md) - [Candel Therapeutics publishes corporate presentation on viral immunotherapies for solid tumors](https://longbridge.com/en/news/282735094.md)